Susquehanna International Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $687K | Sell |
251,748
-65,571
| -21% | -$179K | ﹤0.01% | 3861 |
|
|
2025
Q1 | $533K | Buy |
317,319
+221,643
| +232% | +$372K | ﹤0.01% | 4259 |
|
|
2024
Q4 | $156K | Buy |
95,676
+28,112
| +42% | +$45.8K | ﹤0.01% | 5462 |
|
|
2024
Q3 | $281K | Buy |
67,564
+35,025
| +108% | +$146K | ﹤0.01% | 4386 |
|
|
2024
Q2 | $178K | Sell |
32,539
-26,858
| -45% | -$147K | ﹤0.01% | 4821 |
|
|
2024
Q1 | $594K | Sell |
59,397
-17,919
| -23% | -$179K | ﹤0.01% | 3309 |
|
|
2023
Q4 | $315K | Sell |
77,316
-173,962
| -69% | -$710K | ﹤0.01% | 4468 |
|
|
2023
Q3 | $972K | Buy |
251,278
+17,687
| +8% | +$68.4K | ﹤0.01% | 2597 |
|
|
2023
Q2 | $1.39M | Sell |
233,591
-166,499
| -42% | -$992K | ﹤0.01% | 2307 |
|
|
2023
Q1 | $1.31M | Buy |
400,090
+343,535
| +607% | +$1.12M | ﹤0.01% | 2511 |
|
|
2022
Q4 | $223K | Sell |
56,555
-124,845
| -69% | -$493K | ﹤0.01% | 4316 |
|
|
2022
Q3 | $1.09M | Buy |
181,400
+126,200
| +229% | +$757K | ﹤0.01% | 2429 |
|
|
2022
Q2 | $355K | Sell |
55,200
-74,760
| -58% | -$481K | ﹤0.01% | 3770 |
|
|
2022
Q1 | $1.07M | Buy |
129,960
+50,193
| +63% | +$414K | ﹤0.01% | 2729 |
|
|
2021
Q4 | $1.24M | Buy |
79,767
+27,739
| +53% | +$429K | ﹤0.01% | 2569 |
|
|
2021
Q3 | $1.17M | Buy |
52,028
+4,526
| +10% | +$102K | ﹤0.01% | 2574 |
|
|
2021
Q2 | $934K | Buy |
+47,502
| New | +$934K | ﹤0.01% | 3066 |
|